More than 200,000 units sold monthly at Daiso on average
Cosmetics sales more than quadrupled year over year

Dongwha Pharm's cosmetics business is gradually gaining traction. The cosmetics brand "Fuciderm," launched at Daiso in May this year, surpassed cumulative sales of 1 million units within six months of its launch.

Product images of Dongwha Pharm's "Fusiderm Barrier Repair" SOS Cream and "Fusiderm Trace Repair Capsule Cream."

Product images of Dongwha Pharm's "Fusiderm Barrier Repair" SOS Cream and "Fusiderm Trace Repair Capsule Cream."

View original image

On Nov. 5, Dongwha Pharm said Fuciderm sells an average of more than 200,000 units a month at Daiso alone. Immediately after its launch in May, the "SOS Cream" and moisturizing cream sold out, while the "Scar Repair Capsule Cream," launched in October, ranked No. 1 in beauty sales on Daiso's online store. Cosmetics sales through September this year, including those of the existing brand "Fusidain," increased more than fourfold year over year.


Dongwha Pharm is targeting the high-performance dermacosmetics market by leveraging the brand recognition of Fucidin and the pharmaceutical company's expertise in skin research. The Fuciderm "Barrier Repair" line focuses on skin hydration and barrier care, with ingredients including panthenol. The "Scar Repair" line contains 2% to 15% niacinamide, a brightening ingredient, depending on the product, allowing consumers to choose according to their concerns about skin marks and pigmentation.


Fusidain underwent a rebranding this year and launched "Fusidain 8 Barrier," a product for skin barrier care. Fusidain is sold at retailers including Olive Young and Musinsa, while Fuciderm is sold at Daiso, with products tailored to consumer demand across different sales channels.


This is not the first time Dongwha Pharm has entered the cosmetics business. In 1917, it sold cosmetics such as "Ihwa Bun" and "Dohwa Bun." Building on consumer trust gained through long-established over-the-counter medicines such as Hwalmyeongsu and Fucidin, the company is once again expanding its cosmetics business more than 100 years later.



A Dongwha Pharm representative said, "We are expanding our connections with consumers in the cosmetics business, building on the brand competitiveness we have developed in the over-the-counter medicine sector. We will introduce high-performance derma products that address a wide range of skin concerns and consider expanding our brands and product lines based on market response."


This content was produced with the assistance of AI translation services.

© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.

Today’s Briefing